ElastiMed News
10 articles
growth-positive
/PRNewswire/ -- ElastiMed Ltd. a leading innovator in wearable medical devices for treating and managing lymphatic and venous diseases, is proud to announce...
ElastiMed Ltd., a leader in wearable medical devices for lymphatic and venous diseases, has appointed Dr. Steve Elias to its Medical Advisory Board. Dr. Elias, a renowned expert in vascular surgery and venous medicine, will bring his extensive experience to the company, aligning with ElastiMeds mission to enhance patient care through innovative technology. His appointment is expected to guide ElastiMeds product development and uphold high medical standards. Dr. Eliass involvement underscores ElastiMeds dedication to advancing healthcare with a world-class team of medical experts.
Management Changes
growth-positive
/PRNewswire/ -- ElastiMed Ltd. a leading innovator in wearable medical devices, is proud to announce the appointment of Dr. Amir Belson as a member of its...
ElastiMed Ltd., a leader in wearable medical devices, has appointed Dr. Amir Belson to its Board of Directors. Dr. Belson, known for his extensive experience in the medical device industry and successful M&A transactions, is expected to play a crucial role in guiding ElastiMed as it aims to bring its innovative compression therapy devices to market. The appointment is seen as a strategic move to drive further innovation and growth for the company. ElastiMed is a portfolio company of The Trendlines Group Ltd. and has received funding from the Israeli Innovation Authority, Horizon 2020, and private investors.
Management Changes
ElastiMed is offering a hand to those with leg pain | CTech
growth-positive
Swelling pain in your legs? Israeli startup Elastimed raises $600k with smart sock solution
Israeli startup Elastimed has received a $600,000 investment for its smart sock product designed to help with chronic leg swelling. The product is based on electroactive polymers and provides active medical treatment throughout the day. It is currently in the final stages of development and has successfully passed initial clinical trials. Elastimed plans to use the funds for further clinical trials and to obtain FDA approval for the product.
Investment
growth-positive
Smart socks to treat chronic venous disease - Springwise
Israeli startup ElastiMed has developed a smart compression device to help improve circulation in the legs for people with chronic venous disease. The device is designed to be worn throughout the day and uses electro-active polymers to mimic the natural contractions of the calf muscles. ElastiMed is currently undergoing clinical trials and applying for regulatory approval in Europe and the United States, with hopes to have the devices available for sale by 2019. The market for compression devices to treat chronic venous diseases is estimated to be around $2.2 billion annually.
Customers
growth-positive
Smart medical sock co Elastimed awarded $1.6m EU grant
Israeli smart medical sock company Elastimed has been awarded a $1.6 million grant from the EUs Horizon 2020 program. The grant will be used for product development, clinical studies, production scale-up, marketing, and expanding the companys intellectual property. Elastimed has developed a wearable medical device that improves circulation in the legs for the treatment of venous and lymphatic diseases. The device compresses and massages the legs to increase blood circulation, providing a comfortable and affordable treatment option.
Investment
growth-positive
Israeli Startup's 'Smart' Socks Set To Hit Market Next Year
Israeli startup Elastimed has raised a $1 million investment to develop its smart sock, a wearable medical device that improves circulation in the legs. The sock uses battery-operated technology to activate electric pulses that compress and massage the legs, stimulating blood flow. Elastimeds smart sock is targeted at athletes, pregnant women, and patients with chronic wounds, varicose veins, and other disorders. The company is now focused on clinical trials and regulatory approval, with the aim of bringing the product to market by 2019. Elastimed also plans to develop additional applications using the technology.
InvestmentExpand
growth-positive
Israeli smart sock co ElastiMed raises $1m
Israeli medical device company ElastiMed has raised $1 million in its second financing round, bringing the total raised to date to $2 million. The funds will be used for a clinical study, regulatory filings, and expanding the companys intellectual property. ElastiMed has developed a wearable medical device that improves circulation in the legs for the treatment of venous and lymphatic diseases. The device compresses and massages the legs when stimulated by an electric pulse, providing a comfortable and affordable treatment option. Existing and new investors have shown support and confidence in ElastiMeds future and potential.
Investment
growth-positive
Smart compression stocking goes on easy and feels comfy
Israeli start-up ElastiMed has developed a prototype for a smart medical compression stocking made from a low-cost polymer that stimulates blood flow via an electric pulse generated by a 3V battery. The company recently received $1m in funding from Trendlines Medical Incubator, Singapore-based Pix Vine Capital and a private Israeli investor. The global medical compression market is valued at $1.1bn, and ElastiMeds product aims to increase compliance and improve treatment for conditions such as Chronic Venous Insufficiency (CVI) and Deep Vein Thrombosis (DVT).
Investment
growth-positive
Israeli compression therapy co ElastiMed raises $1m
Israeli compression therapy company ElastiMed has raised $1 million in funding. The company is developing a wearable device using smart materials to treat Chronic Venous Insufficiency (CVI) and prevent Deep Venous Thrombosis (DVT). The current compression therapy devices are inconvenient and difficult to apply, leading to low patient compliance. ElastiMeds innovative stocking aims to improve patient compliance and provide a solution for patients worldwide suffering from CVI.
Investment